Cameron, D., Brown, J., Dent, R., Jackisch, C., Mackey, J., Pivot, X., . . . Bell, R. (2013). Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): Primary results of a randomised, phase 3 trial. The Lancet Publishing Group.
Chicago Style (17th ed.) CitationCameron, David, et al. Adjuvant Bevacizumab-containing Therapy in Triple-negative Breast Cancer (BEATRICE): Primary Results of a Randomised, Phase 3 Trial. The Lancet Publishing Group, 2013.
MLA (9th ed.) CitationCameron, David, et al. Adjuvant Bevacizumab-containing Therapy in Triple-negative Breast Cancer (BEATRICE): Primary Results of a Randomised, Phase 3 Trial. The Lancet Publishing Group, 2013.
Warning: These citations may not always be 100% accurate.